Profiling drug candidates
for liver disease
Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.
Enabling cures for liver disease through highly predictive in vitro modeling
We generate high-quality, phenotypically relevant disease modeled hepatocytes that can be utilized to screen compounds.
Specialist CRO focused on delivering liver and metabolic disease models

Highly Predictive
Hepatocyte-like cells successfully recapitulate key aspects of disease pathophysiology across a wide-range of conditions that affect different aspects of liver function.

Scalable
DefiniGEN’s proprietary differentiation protocol permits large-scale generation of hepatocyte-like cells with field leading purity and functionality.

Optimized Bioassay Development
Optimized bioassays that can accurately evaluate compound potency, efficacy and delivery.
Scientific expertise
15
10
10 years of iPSC
6
10
